Dexmedetomidine as an Adjunct to Transversus Abdominis Plane Block in Patients Undergoing Cancer Surgeries: A Systematic Review and Meta-Analysis
Life · 23.07.2026 · 16 (8) · 1217
DOI: 10.3390/life16081217 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life, online erschienen am 23.07.2026. Verfasst von Rana Abdulmohsen Alotaibi und 13 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Taif University, Taif 21944, Saudi Arabia. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cancer rates are increasing significantly worldwide, with surgical intervention being the most convenient intervention. Transversus abdominis plane (TAP) block has been proven to enhance postoperative opioid use and its associated complications. Additionally, dexmedetomidine has been reported to provide effective analgesia with relatively minimal respiratory complications. This systematic review and meta-analysis aims to explore the efficacy of combining dexmedetomidine with transversus abdominis plane (TAP) block compared to transversus abdominis plane (TAP) block alone in patients undergoing various cancer surgeries as outcomes may also be influenced by surgical and patient-related factors.
Methods
We conducted a comprehensive literature search across PubMed/MEDLINE, Scopus, Web of Science, Cochrane CENTRAL, and Embase to identify randomized controlled trials evaluating the efficacy and safety of dexmedetomidine as an adjunct to transversus abdominis plane (TAP) block in patients undergoing cancer surgery. Data were extracted from the six eligible randomized controlled trials that met the predefined inclusion criteria, and a random-effects meta-analysis was performed using RevMan software Version 5.4.
Results
The meta-analysis found that dexmedetomidine as an adjunct to transversus abdominis plane (TAP) block was more effective than transversus abdominis plane (TAP) block alone in reducing the mean arterial pressure and the mean heart rate 2 h postoperatively (MD −6.46, 95% CI [−8.63; −4.30], p < 0.0001) and (MD −5.44, 95% CI [−7.67; −3.20], p < 0.0001). The duration until the first rescue analgesia was significantly longer in the TAP–DEX group (MD 3.75, 95% CI [3.08; 4.43], p < 0.0001). The overall patient satisfaction with postoperative pain management demonstrated statistically significant improvement compared to the TAP group (RR 1.31, 95% CI [1.13; 1.53], p = 0.0005). visual analog scale (VAS) pain scores, which are used to assess pain intensity, were significantly lower at rest and during movement 2 h postoperatively in the TAP-DEX group, although some complex patients may have difficulty using visual analog scale (VAS) pain scores accurately. Therefore, the Numeric Rating Scale (NRS) may be considered as an alternative tool.
Conclusions
Compared to transversus abdominis plane (TAP) block alone, the dexmedetomidine and transversus abdominis plane (TAP) block arm showed a statistically significant difference in time to first rescue analgesia, patient overall satisfaction, nausea, and vomiting. However, no statistical significance difference was found across the remaining outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmacy, Taif University, Taif 21944, Saudi Arabia.
- Anesthesiology and Intensive Care, Ohud Hospital, Minisrty of Heakth, Al Madinah Al Munawwarah 42394, Saudi Arabia.
- College of Medicine, Umm Al-Qura University, Makkah 21955, Saudi Arabia.
- College of Pharmacy, Northern Border University, Arar 91431, Saudi Arabia.
- College of Pharmacy, Taibah University, Al Madinah Al Munawwarah 42353, Saudi Arabia.
- Community Pharmacy Outlet Plus, Alhusiba, Dumat al-Jandal 74821, Saudi Arabia.
ORCID-Profile: Rana Abdulmohsen Alotaibi, Wafaa T Alruwaili, Areej Jarbou Bahrawi
Zitieren
APA
Alotaibi, R. A., Alharthi, M. O., Shokry, H. I., Samandar, A. F., Alruwaili, W. T., Aljohani, M. H., Alhamed, S. S., Mutairi, A. H. A., Alruwaili, E. A., Alzahrani, R. A., Alzahrani, A. T., Bahrawi, A. J., Alghamdi, N. M., & Alkhulayfi, M. A. (2026). Dexmedetomidine as an Adjunct to Transversus Abdominis Plane Block in Patients Undergoing Cancer Surgeries: A Systematic Review and Meta-Analysis. Life, 16(8), 1217. https://doi.org/10.3390/life16081217
Vancouver
Alotaibi RA, Alharthi MO, Shokry HI, Samandar AF, Alruwaili WT, Aljohani MH, et al. Dexmedetomidine as an Adjunct to Transversus Abdominis Plane Block in Patients Undergoing Cancer Surgeries: A Systematic Review and Meta-Analysis. Life. 2026;16(8):1217. doi:10.3390/life16081217
BibTeX
@article{Alotaibi2026,
author = {Alotaibi, Rana Abdulmohsen and Alharthi, Manal Owaid and Shokry, Hazem Ibrahim and Samandar, Abdulaziz Fahad and Alruwaili, Wafaa T and Aljohani, Muzun Hamed and Alhamed, Shatha Salem and Mutairi, Amal Hussain Al and Alruwaili, Elaf Abdullah and Alzahrani, Rawan Ahmed and Alzahrani, Ahmed Tariq and Bahrawi, Areej Jarbou and Alghamdi, Nawaf Mohammed and Alkhulayfi, Mansour Abdulrahman},
title = {Dexmedetomidine as an Adjunct to Transversus Abdominis Plane Block in Patients Undergoing Cancer Surgeries: A Systematic Review and Meta-Analysis},
journal = {Life},
year = {2026},
volume = {16},
number = {8},
pages = {1217},
doi = {10.3390/life16081217}
}
EUVIMED